ANALOGUES OF THE AZINOMYCINS AS ANTI-TUMOUR AGENTS AND AS PRODRUGS
申请人:University of Bradford
公开号:EP1858836B1
公开(公告)日:2009-11-18
Analogues of the Azinomycins as Anti-Tumour Agents and as Prodrugs
申请人:Searcey Mark
公开号:US20090233966A1
公开(公告)日:2009-09-17
Compounds of general formula (I) or a salt thereof in which R
1
is preferably an aromatic DNA binding subunit are oxidation-activated prodrugs. The compounds are expected to be converted into an epoxide at the alkene to which R
2
is attached by cytochrome P450, in particular CYPIBI, expressed at high levels in tumours. R
3
preferably comprises a Nitrogen mustard to provide a prodrug which has 2 alkylating groups. The prodrugs are expected to be activated preferentially in tumour cells.